£4.2M
The round was co-led by Oxford Science Enterprises and Cedars-Sinai to accelerate US expansion.
Kneu Health
A precision neurology platform for tracking Parkinson and dementia via smartphones.
£4.2MTotal raised
Kneu Health develops a precision neurology platform that tracks motor, speech and cognitive changes via a smartphone application. The company builds population scale datasets to help manage neurodegenerative conditions such as Parkinson and dementia.
Categories
Founders
Caroline Cake
co-founder and CEO
Caroline brings healthcare sector experience from her time leading Health Data Research UK and Kneu Health. She previously held roles at McKinsey & Company and Oxford Science Enterprises.
LinkedIn